<unk>  is a substance P/neurokinin 1 (NK1) receptor antagonist that is FDA approved for the prevention of delayed nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including, but not limited to, highly emetogenic chemotherapy.   Common adverse reactions include neutropenia, hiccups, decreased appetite and dizziness.
Rolapitant
Terguride
Isosorbide dinitrate
Buflomedil
Cobicistat
Eluxadoline
Sildenafil
Bepotastine Besilate